Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 4/20 | 0.43 |
| ▸ | FDPS | P14324 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL641726 | 1.00 | SMPD1 (0.43) | SMPD1FDPSTSHRTHRBOPRM1 | |
| SCHEMBL3073022 | 1.00 | SMPD1 (0.43) | SMPD1FDPSTSHRTHRBOPRM1 | |
| SCHEMBL641208 | 0.97 | FDPS (0.41) | SMPD1FDPSTSHRTHRBOPRM1 | |
| SCHEMBL504337 | 0.90 | FDPS (0.39) | SMPD1FDPSTSHRTHRBOPRM1 | |
| Ammonia Solution, Strong SCHEMBL28391001 | 0.87 | FDPS (0.38) | SMPD1FDPSTSHROPRM1 | |
| SCHEMBL6568281 | 0.81 | SMPD1 (0.45) | SMPD1FDPSTSHRTHRBOPRM1 | |
| SCHEMBL3676595 | 0.81 | FDPS (0.45) | SMPD1FDPSSPHK1GGPS1 | |
| SCHEMBL9422192 | 0.81 | FDPS (0.45) | SMPD1FDPSSPHK1GGPS1 | |
| SCHEMBL123833 | 0.81 | FDPS (0.45) | SMPD1FDPSSPHK1GGPS1 | |
| SCHEMBL3677155 | 0.81 | FDPS (0.45) | SMPD1FDPSSPHK1GGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090233935-A1 | Methods for Fabrication of Antimicrobial Surfaces | RESEARCH FOUNDATION OF CITY UNIVERSITY OF NEW YORK (US) | 2009-09-17 | — | — | US | disclosed |
| EP-1945229-A2 | METHODS FOR FABRICATION OF ANTIMICROBIAL SURFACES | Research Foundation of the City University of New York (US) | 2008-07-23 | — | — | EP | disclosed |
| WO-2008018890-A2 | METHODS FOR FABRICATION OF ANTIMICROBIAL SURFACES | RESEARCH FOUNDATION OF CITY UNIVERSITY OF NEW YORK (US) | 2008-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233935-A1 | Methods for Fabrication of Antimicrobial Surfaces | ADH1A, ADH1C, HAO2 | SMPD1 2643/4885FDPS 3471/4885TSHR 2444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.